Diagnostic Substances Industry

Below are the top diagnostic substances stocks on the NYSE and the NASDAQ in terms of profit margin. The trailing-twelve-month profit margin at Trinity Biotech plc (NASDAQ: TRIB) is 20.71%. Trinity Biotech's ROA for the same period is 5.89%. The trailing-twelve-month profit margin at Meridian...

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of return on equity. The trailing-twelve-month return on equity at Meridian Bioscience (NASDAQ: VIVO) is 22.58%. Meridian Bioscience's revenue for the same period is $171.20 million. The trailing-twelve-...

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of earnings estimate for the next year. Neogen (NASDAQ: NEOG) is likely to earn $1.30 per share in the next year ending May, 2014. Neogen's PEG ratio is 2.06. Abaxis (NASDAQ: ABAX) may earn $1.11 per...

Below are the top diagnostic substances stocks on the NASDAQ in terms of profit margin. The trailing-twelve-month profit margin at Trinity Biotech plc (NASDAQ: TRIB) is 20.32%. Trinity Biotech's ROE for the same period is 10.69%. The trailing-twelve-month profit margin at Meridian Bioscience (...

Below are the top diagnostic substances stocks on the NASDAQ in terms of cash. AMAG Pharmaceuticals (NASDAQ: AMAG) had $207.25 million in total cash for the latest quarter. However, AMAG Pharmaceuticals had no debt for the same period. IDEXX Laboratories (NASDAQ: IDXX) had $201.81 million in...

Below are the top diagnostic substances stocks on the NASDAQ in terms of cash. AMAG Pharmaceuticals (NASDAQ: AMAG) had $200.45 million in total cash for the latest quarter. However, AMAG Pharmaceuticals had no debt for the same period. IDEXX Laboratories (NASDAQ: IDXX) had $185.49 million in...

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of revenue. The trailing-twelve-month revenue at Neogen (NASDAQ: NEOG) is $179.10 million. Neogen had $61.33 million in total cash for the latest quarter. The trailing-twelve-month revenue at Meridian...

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of profit margin. The trailing-twelve-month profit margin at Trinity Biotech plc (NASDAQ: TRIB) is 20.11%. TRIB's revenue for the same period is $79.32 million. The trailing-twelve-month profit margin at...

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of PEG ratio. Trinity Biotech plc (NASDAQ: TRIB) has a PEG ratio of 0.81. TRIB's trailing-twelve-month revenue is $77.95 million. Meridian Bioscience Inc (NASDAQ: VIVO) has a PEG ratio of 1.20. VIVO's...

Below are the top diagnostic substances stocks on the NYSE and the NASDAQ in terms of profit margin. The trailing-twelve-month profit margin at Trinity Biotech plc (NASDAQ: TRIB) is 19.70%. TRIB's revenue for the same period is $77.18 million. The trailing-twelve-month profit margin at Meridian...

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of PEG ratio. Trinity Biotech plc (NASDAQ: TRIB) has a PEG ratio of 0.89. TRIB's trailing-twelve-month revenue is $77.18 million. Meridian Bioscience Inc (NASDAQ: VIVO) has a PEG ratio of 1.29. VIVO's...

Below are the top diagnostic substances stocks on the NASDAQ in terms of cash. AMAG Pharmaceuticals Inc (NASDAQ: AMAG) had $229.34 million in total cash and no debt for the latest quarter. IDEXX Laboratories Inc (NASDAQ: IDXX) had $181.50 million in total cash and $157.64 million in total debt...

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of revenue. The trailing-twelve-month revenue at Neogen Corporation (NASDAQ: NEOG) is $172.68 million. NEOG's PEG ratio is 1.53. The trailing-twelve-month revenue at Meridian Bioscience Inc (NASDAQ: VIVO...

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of earnings per share. The trailing-twelve-month earnings per share at Trinity Biotech plc (NASDAQ: TRIB) is $2.78. TRIB's ROE for the same period is 53.87%. The trailing-twelve-month earnings per share...

Below are the top small-cap diagnostic substances stocks on the NYSE, the NASDAQ and the AMEX in terms of return on equity. The trailing-twelve-month return on equity at Trinity Biotech plc (NASDAQ: TRIB) is 53.87%. TRIB's PEG ratio is 0.94. The trailing-twelve-month return on equity at Accelr8...